Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry W Long

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Nature Communications|March 18, 2020
Chromatin accessibility promotes hematopoietic and leukemia stem cell activityLucia Cabal-Hierro, Peter van Galen, Miguel A Prado, et al.
Oncotarget|February 14, 2018
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2024
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapiesMarie-Anne Goyette, Laura E Stevens, Carolyn R DePinho, et al.
Cell|June 19, 2018
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerDavid Y Takeda, Sándor Spisák, Ji-Heui Seo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2025
METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformationYihao Li, Xintao Qiu, Zachary Sandusky, et al.
Cell Reports|November 15, 2018
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 OverexpressionCody T Mowery, Jaime M Reyes, Lucia Cabal-Hierro, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Nature Communications|March 18, 2020
Chromatin accessibility promotes hematopoietic and leukemia stem cell activityLucia Cabal-Hierro, Peter van Galen, Miguel A Prado, et al.
Oncotarget|February 14, 2018
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signalingHari Singhal, Marianne E Greene, Allison L Zarnke, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 17, 2017
Embryonic transcription factor SOX9 drives breast cancer endocrine resistanceRinath Jeselsohn, MacIntosh Cornwell, Matthew Pun, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Increased chromatin accessibility mediated by nuclear factor I drives transition to androgen receptor splice variant dependence in castration-resistant prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 6, 2024
Cancer-stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapiesMarie-Anne Goyette, Laura E Stevens, Carolyn R DePinho, et al.
Cell|June 19, 2018
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate CancerDavid Y Takeda, Sándor Spisák, Ji-Heui Seo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2025
METTL3-dependent m6A RNA methylation suppresses aberrant mammary epithelial differentiation and neoplastic transformationYihao Li, Xintao Qiu, Zachary Sandusky, et al.
Cell Reports|November 15, 2018
Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 OverexpressionCody T Mowery, Jaime M Reyes, Lucia Cabal-Hierro, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Cell Reports|December 22, 2024
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancerLarysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Pageof 10